Palomino Laboratories (PALX) Income from Continuing Operations (2023 - 2025)

Palomino Laboratories' Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 1604885.0 for Q3 2025.

• In Q3 2025, Income from Continuing Operations fell 1383621.55% year-over-year to 1604885.0; the TTM figure through Sep 2025 stood at 1811778.0 (down 1467.92% YoY), while the FY2024 annual figure was 145866.0, down 73.78% from the prior year.
• Income from Continuing Operations came in at 1604885.0 for Q3 2025 at Palomino Laboratories, down from 43775.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 116.0 in Q3 2024 to a low of 1604885.0 in Q3 2025.
• A 3-year average of 218910.44 and a median of 42863.0 in 2023 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations surged 100.27% in 2024 and slumped 1383621.55% in 2025, its largest moves.
• Palomino Laboratories' Income from Continuing Operations stood at 32574.0 in 2023, then plunged by 323.53% to 137962.0 in 2024, then sank by 1063.28% to 1604885.0 in 2025.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 1604885.0, 43775.0, and 25156.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison